Amylyx Pharmaceuticals (AMLX) Property, Plant & Equipment (Net) (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.96 Bn |
| 10 | Amylyx Pharmaceuticals | 4.34 Bn | 4.34 Bn | - | 199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199,000.00 |
| Jun 30, 2026 | 199,000.00 |
| Mar 31, 2026 | 212,000.00 |
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 310,000.00 |
| Dec 31, 2025 | 310,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 445,000.00 |
| Jun 30, 2025 | 445,000.00 |
| Mar 31, 2025 | 816,000.00 |
| Mar 31, 2025 | 816,000.00 |
| Dec 31, 2024 | 961,000.00 |
| Dec 31, 2024 | 961,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.46 Mn |